CASE STUDY

SHARE THIS

Two similar global clinical studies were testing a study drug in patients with two rare forms of cancer: Richter’s Syndrome and Diffuse Large B-cell Lymphoma.

Learn how our team helped increase exposure for these rare indications, enabling a steady stream of qualified patients to be directed to over a hundred sites across a total of eight months, resulting in dozens of new screens and randomizations.

 
SHARE THIS


Subscribe to our newsletter

For the latest news & resources, sign up for our monthly newsletter.

I am a



Thank you for subscribing!

Something wrong, please try again!

ClinEdge (en-US)//www.instagram.com/clin_edge//www.facebook.com/clinedge//twitter.com/clinedge//www.linkedin.com/company/clinedgehttps://d24fch2vleri7h.cloudfront.net/img/clinedge-logo2.png?mtime=20210326174318&focal=none+18574960054info@clin-edge.comsales ClinEdge (en-US)Every Stage of Every Study. Creating innovative solutions that connect and empower the clinical trial ecosystemHomehttps://clin-edge.comCaseshttps://clin-edge.com/caseshttps://clin-edge.com/cases/richters-syndrome-diffuse-large-b-cell-lymphoma-studies